Skip to main content
Livermore
Livermore
ZHEN

Bruce & Co., Inc.

SEC CIK
0001358331
Latest filing
Aug 14, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by Bruce & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2026)
989,188
Value
$2.67M
% of portfolio
0.7%
Quarters held
22
Since Q1 2021
Holdings of FATE by Bruce & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026989,188$2.67M0.7%+200,000+25.3%AddedHolders
Q1 2026789,188$947.0K0.3%+60,000+8.2%AddedHolders
Q4 2025729,188$716.5K0.2%00.0%UnchangedHolders
Q3 2025729,188$918.8K0.3%+300,000+69.9%AddedHolders
Q2 2025429,188$480.7K0.2%−120,812−22.0%ReducedHolders
Q1 2025550,000$434.5K0.1%+200,000+57.1%AddedHolders
Q4 2024350,000$577.5K0.2%00.0%UnchangedHolders
Q3 2024350,000$1.23M0.4%+50,000+16.7%AddedHolders
Q2 2024300,000$984.0K0.3%+157,000+109.8%AddedHolders
Q1 2024143,000$1.05M0.3%00.0%UnchangedHolders
Q4 2023143,000$534.8K0.2%−57,000−28.5%ReducedHolders
Q3 2023200,000$424.0K0.1%00.0%UnchangedHolders
Q2 2023200,000$956.0K0.3%00.0%UnchangedHolders
Q1 2023200,000$1.14M0.3%+143,000+250.9%AddedHolders
Q4 202257,000$575.1K0.1%00.0%UnchangedHolders
Q3 202257,000$1.28M0.4%00.0%UnchangedHolders
Q2 202257,000$1.41M0.3%00.0%UnchangedHolders
Q1 202257,000$2.21M0.5%00.0%UnchangedHolders
Q4 202157,000$3.33M0.7%00.0%UnchangedHolders
Q3 202157,000$3.38M0.7%−5,000−8.1%ReducedHolders
Q2 202162,000$5.38M1.0%−3,000−4.6%ReducedHolders
Q1 202165,000$5.36M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.